Akerman BR[au] - Search Results

Year	Number of Results
1990	1
1991	1
1992	3
1994	1
1995	2
1996	1
1997	1
1998	1
1999	3
2000	2
2001	2
2007	1
2023	0

1

Mutations participating in interallelic complementation in propionic acidemia.

Gravel RA, Akerman BR, Lamhonwah AM, Loyer M, Léon-del-Rio A, Italiano I. Gravel RA, et al. Among authors: akerman br. Am J Hum Genet. 1994 Jul;55(1):51-8. Am J Hum Genet. 1994. PMID: 8023851 Free PMC article.

2

Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort.

Akerman BR, Lemass H, Chow LM, Lambert DM, Greenberg C, Bibeau C, Mamer OA, Treacy EP. Akerman BR, et al. Mol Genet Metab. 1999 Sep;68(1):24-31. doi: 10.1006/mgme.1999.2885. Mol Genet Metab. 1999. PMID: 10479479

3

Population-specific polymorphisms of the human FMO3 gene: significance for detoxication.

Cashman JR, Akerman BR, Forrest SM, Treacy EP. Cashman JR, et al. Among authors: akerman br. Drug Metab Dispos. 2000 Feb;28(2):169-73. Drug Metab Dispos. 2000. PMID: 10640514

4

Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.

Phaneuf D, Wakamatsu N, Huang JQ, Borowski A, Peterson AC, Fortunato SR, Ritter G, Igdoura SA, Morales CR, Benoit G, Akerman BR, Leclerc D, Hanai N, Marth JD, Trasler JM, Gravel RA. Phaneuf D, et al. Among authors: akerman br. Hum Mol Genet. 1996 Jan;5(1):1-14. doi: 10.1093/hmg/5.1.1. Hum Mol Genet. 1996. PMID: 8789434

5

Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication.

Treacy EP, Akerman BR, Chow LM, Youil R, Bibeau C, Lin J, Bruce AG, Knight M, Danks DM, Cashman JR, Forrest SM. Treacy EP, et al. Among authors: akerman br. Hum Mol Genet. 1998 May;7(5):839-45. doi: 10.1093/hmg/7.5.839. Hum Mol Genet. 1998. PMID: 9536088

6

Molecular basis of hexosaminidase A deficiency and pseudodeficiency in the Berks County Pennsylvania Dutch.

Mules EH, Hayflick S, Dowling CE, Kelly TE, Akerman BR, Gravel RA, Thomas GH. Mules EH, et al. Among authors: akerman br. Hum Mutat. 1992;1(4):298-302. doi: 10.1002/humu.1380010406. Hum Mutat. 1992. PMID: 1301937

7

A second, large deletion in the HEXB gene in a patient with infantile Sandhoff disease.

Zhang ZX, Wakamatsu N, Akerman BR, Mules EH, Thomas GH, Gravel RA. Zhang ZX, et al. Among authors: akerman br. Hum Mol Genet. 1995 Apr;4(4):777-80. doi: 10.1093/hmg/4.4.777. Hum Mol Genet. 1995. PMID: 7633435 No abstract available.

8

In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene.

Lambert DM, Mamer OA, Akerman BR, Choinière L, Gaudet D, Hamet P, Treacy EP. Lambert DM, et al. Among authors: akerman br. Mol Genet Metab. 2001 Jul;73(3):224-9. doi: 10.1006/mgme.2001.3189. Mol Genet Metab. 2001. PMID: 11461189

9

Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.

Akerman BR, Natowicz MR, Kaback MM, Loyer M, Campeau E, Gravel RA. Akerman BR, et al. Am J Hum Genet. 1997 May;60(5):1099-106. Am J Hum Genet. 1997. PMID: 9150157 Free PMC article.

10

A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.

Akerman BR, Zielenski J, Triggs-Raine BL, Prence EM, Natowicz MR, Lim-Steele JS, Kaback MM, Mules EH, Thomas GH, Clarke JT, et al. Akerman BR, et al. Hum Mutat. 1992;1(4):303-9. doi: 10.1002/humu.1380010407. Hum Mutat. 1992. PMID: 1301938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results